JR

Jigna Rajeshkumar Gajara

Active Director Designated Partner DIN 09352549
DIN 09352549 First appointment Oct 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Jigna Rajeshkumar Gajara

Data last updated:

Jigna Rajeshkumar Gajara is a Designated Partner at Navkaar Pharmacy Llp (since 2021). The company operates in Pharma.

DIN 09352549
Primary Designation Designated Partner
Industry Pharma
First Appointment 21 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Oct 20212021Active

Board colleagues of Jigna Rajeshkumar Gajara

NameDINCompanyDesignation
Nandini Sanjay Shah09339106Navkaar Pharmacy LlpDesignated Partner
Sarita Naresh Mehta09339107Navkaar Pharmacy LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Navkaar Pharmacy Llp
Premium access

Shareholding and investment profile for Jigna Rajeshkumar Gajara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jigna Rajeshkumar Gajara

Jigna Rajeshkumar Gajara currently holds 1 directorship: Navkaar Pharmacy Llp (Designated Partner, since 21 Oct 2021).

Jigna Rajeshkumar Gajara was first appointed on 21 Oct 2021 as Designated Partner at Navkaar Pharmacy Llp.

The current boards of Jigna Rajeshkumar Gajara's companies include Nandini Sanjay Shah (Navkaar Pharmacy Llp), Sarita Naresh Mehta (Navkaar Pharmacy Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available